The prognostic role of MRI-based radiomics in tongue carcinoma: a multicentric validation study.

Head and neck cancer Omics Precision medicine Prognosis prediction Radiomics Tongue cancer

Journal

La Radiologia medica
ISSN: 1826-6983
Titre abrégé: Radiol Med
Pays: Italy
ID NLM: 0177625

Informations de publication

Date de publication:
03 Aug 2024
Historique:
received: 27 03 2024
accepted: 17 07 2024
medline: 4 8 2024
pubmed: 4 8 2024
entrez: 3 8 2024
Statut: aheadofprint

Résumé

Radiomics is an emerging field that utilizes quantitative features extracted from medical images to predict clinically meaningful outcomes. Validating findings is crucial to assess radiomics applicability. We aimed to validate previously published magnetic resonance imaging (MRI) radiomics models to predict oncological outcomes in oral tongue squamous cell carcinoma (OTSCC). Retrospective multicentric study on OTSCC surgically treated from 2010 to 2019. All patients performed preoperative MRI, including contrast-enhanced T1-weighted (CE-T1), diffusion-weighted sequences and apparent diffusion coefficient map. We evaluated overall survival (OS), locoregional recurrence-free survival (LRRFS), cause-specific mortality (CSM). We elaborated different models based on clinical and radiomic data. C-indexes assessed the prediction accuracy of the models. We collected 112 consecutive independent patients from three Italian Institutions to validate the previously published MRI radiomic models based on 79 different patients. The C-indexes for the hybrid clinical-radiomic models in the validation cohort were lower than those in the training cohort but remained > 0.5 in most cases. CE-T1 sequence provided the best fit to the models: the C-indexes obtained were 0.61, 0.59, 0.64 (pretreatment model) and 0.65, 0.69, 0.70 (posttreatment model) for OS, LRRFS and CSM, respectively. Our clinical-radiomic models retain a potential to predict OS, LRRFS and CSM in heterogeneous cohorts across different centers. These findings encourage further research, aimed at overcoming current limitations, due to the variability of imaging acquisition, processing and tumor volume delineation.

Identifiants

pubmed: 39096355
doi: 10.1007/s11547-024-01859-y
pii: 10.1007/s11547-024-01859-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Lambin P, Rios-Velazquez E, Leijenaar R, Carvalho S, van Stiphout RG, Granton P, Zegers CM, Gillies R, Boellard R, Dekker A, Aerts HJ (2012) Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer 48(4):441–446. https://doi.org/10.1016/j.ejca.2011.11.036
doi: 10.1016/j.ejca.2011.11.036 pubmed: 22257792 pmcid: 4533986
Keek SA, Leijenaar RT, Jochems A, Woodruff HC (2018) A review on radiomics and the future of theranostics for patient selection inprecision medicine. Br J Radiol 91(1091):20170926. https://doi.org/10.1259/bjr.201709262
doi: 10.1259/bjr.201709262 pubmed: 29947266 pmcid: 6475933
Volpe S, Mastroleo F, Krengli M, Jereczek-Fossa BA (2023) Quo vadis Radiomics? Bibliometric analysis of 10-year Radiomics journey. Eur Radiol 33(10):6736–6745. https://doi.org/10.1007/s00330-023-09645-6
doi: 10.1007/s00330-023-09645-6 pubmed: 37071161 pmcid: 10110486
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue RTHM, Even AJG, Jochems A, van Wijk Y, Woodruff H, van Soest J, Lustberg T, Roelofs E, van Elmpt W, Dekker A, Mottaghy FM, Wildberger JE, Walsh S (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749–762. https://doi.org/10.1038/nrclinonc.2017.141
doi: 10.1038/nrclinonc.2017.141 pubmed: 28975929
Shahzadi I, Zwanenburg A, Lattermann A, Linge A, Baldus C, Peeken JC, Combs SE, Diefenhardt M, Rödel C, Kirste S, Grosu AL, Baumann M, Krause M, Troost EGC, Löck S (2022) Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models. Sci Rep 12(1):10192. https://doi.org/10.1038/s41598-022-13967-8
doi: 10.1038/s41598-022-13967-8 pubmed: 35715462 pmcid: 9205935
Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387. https://doi.org/10.1016/j.ejca.2018.07.005
doi: 10.1016/j.ejca.2018.07.005 pubmed: 30100160
Calabrese L, Bruschini R, Giugliano G, Ostuni A, Maffini F, Massaro MA, Santoro L, Navach V, Preda L, Alterio D, Ansarin M, Chiesa F (2011) Compartmental tongue surgery: long term oncologic results in the treatment of tongue cancer. Oral Oncol 47(3):174–179. https://doi.org/10.1016/j.oraloncology.2010.12.006
doi: 10.1016/j.oraloncology.2010.12.006 pubmed: 21257337
Brenner H (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 360(9340):1131–1135. https://doi.org/10.1016/S0140-6736(02)11199-8
doi: 10.1016/S0140-6736(02)11199-8 pubmed: 12387961
Zanoni DK, Montero PH, Migliacci JC, Shah JP, Wong RJ, Ganly I, Patel SG (2019) Survival outcomes after treatment of cancer of the oral cavity (1985–2015). Oral Oncol 90:115–121. https://doi.org/10.1016/j.oraloncology.2019.02.001
doi: 10.1016/j.oraloncology.2019.02.001 pubmed: 30846169 pmcid: 6417804
Mossinelli C, Tagliabue M, Ruju F, Cammarata G, Volpe S, Raimondi S, Zaffaroni M, Isaksson JL, Garibaldi C, Cremonesi M, Corso F, Gaeta A, Emili I, Zorzi S, Alterio D, Marvaso G, Pepa M, De Fiori E, Maffini F, Preda L, Benazzo M, Jereczek-Fossa BA, Ansarin M (2023) The role of radiomics in tongue cancer: a new tool for prognosis prediction. Head Neck 45(4):849–861. https://doi.org/10.1002/hed.27299
doi: 10.1002/hed.27299 pubmed: 36779382
Wang F, Tan R, Feng K, Hu J, Zhuang Z, Wang C, Hou J, Liu X (2022) Magnetic resonance imaging-based radiomics features associated with depth of invasion predicted lymph node metastasis and prognosis in tongue cancer. J Magn Reson Imaging 56(1):196–209. https://doi.org/10.1002/jmri.28019
doi: 10.1002/jmri.28019 pubmed: 34888985
Park H, Lim Y, Ko ES, Cho HH, Lee JE, Han BK, Ko EY, Choi JS, Park KW (2018) Radiomics signature on magnetic resonance imaging: association with disease-free survival in patients with invasive breast cancer. Clin Cancer Res 24(19):4705–4714. https://doi.org/10.1158/1078-0432.CCR-17-3783
doi: 10.1158/1078-0432.CCR-17-3783 pubmed: 29914892
Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X, Sun K, Li L, Li B, Wang M, Tian J (2019) The applications of radiomics in precision diagnosis and treatment of oncology: opportunities and challenges. Theranostics 9(5):1303–1322. https://doi.org/10.7150/thno.30309
doi: 10.7150/thno.30309 pubmed: 30867832 pmcid: 6401507
Kramer AA, Zimmerman JE (2007) Assessing the calibration of mortality benchmarks in critical care: the Hosmer–Lemeshow test revisited. Crit Care Med 35(9):2052–2056. https://doi.org/10.1097/01.CCM.0000275267.64078.B0
doi: 10.1097/01.CCM.0000275267.64078.B0 pubmed: 17568333
Moskowitz CS, Welch ML, Jacobs MA, Kurland BF, Simpson AL (2022) Radiomic analysis: study design, statistical analysis, and other bias mitigation strategies. Radiology 304(2):265–273. https://doi.org/10.1148/radiol.211597
doi: 10.1148/radiol.211597 pubmed: 35579522
Kazmierski M, Welch M, Kim S, McIntosh C, Rey-McIntyre K, Huang SH, Patel T, Tadic T, Milosevic M, Liu FF, Ryczkowski A, Kazmierska J, Ye Z, Plana D, Aerts HJWL, Kann BH, Bratman SV, Hope AJ, Haibe-Kains B (2023) Multi-institutional prognostic modeling in head and neck cancer: evaluating impact and generalizability of deep learning and radiomics. Cancer Res Commun 3(6):1140–1151. https://doi.org/10.1158/2767-9764.CRC-22-0152
doi: 10.1158/2767-9764.CRC-22-0152 pubmed: 37397861 pmcid: 10309070
Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–4. https://doi.org/10.1245/s10434-010-0985-4
doi: 10.1245/s10434-010-0985-4 pubmed: 20180029
Brierley JD, Gospodarowicz MK, Wittekind C (eds) (2016) TNM classification of malignant tumours, 8th edn. Wiley-Blackwell, Hoboken
Alterio D, Preda L, Volpe S, Giannitto C, Riva G, KamgaPounou FA, Atac M, Giugliano G, Bruschini R, Ferrari A, Marvaso G, Cossu Rocca M, Verri E, Rossi D, Bellomi M, Jereczek-Fossa BA, Orecchia R, Ansarin M (2020) Impact of a dedicated radiologist as a member of the head and neck tumour board: a single-institution experience. Acta Otorhinolaryngol Ital 40(1):26–32. https://doi.org/10.14639/0392-100X-N0326
doi: 10.14639/0392-100X-N0326 pubmed: 32275646 pmcid: 7147540
NCCN Guidelines Version 1.2024—October 9, 2023 Head and neck cancers. Accessed Oct 2023. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf9
Orlhac F, Lecler A, Savatovski J, Goya-Outi J, Nioche C, Charbonneau F, Ayache N, Frouin F, Duron L, Buvat I (2021) How can we combat multicenter variability in MR radiomics? Validation of a correction procedure. Eur Radiol 31(4):2272–2280. https://doi.org/10.1007/s00330-020-07284-9
doi: 10.1007/s00330-020-07284-9 pubmed: 32975661
Ansarin M, Bruschini R, Navach V, Giugliano G, Calabrese L, Chiesa F, Medina JE, Kowalski LP, Shah JP (2019) Classification of glossectomies: proposal for tongue cancer resections. Head Neck 41(3):821–827. https://doi.org/10.1002/hed.25466
doi: 10.1002/hed.25466 pubmed: 30600861 pmcid: 6590454
van der Hulst HJ, Jansen RW, Vens C, Bos P, Schats W, de Jong MC, Martens RM, Bodalal Z, Beets-Tan RGH, van den Brekel MWM, de Graaf P, Castelijns JA (2023) The prediction of biological features using magnetic resonance imaging in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Cancers 15(20):5077. https://doi.org/10.3390/cancers15205077
doi: 10.3390/cancers15205077 pubmed: 37894447 pmcid: 10605807
Ying Y, Xiaofeng T (2022) Value of MRI radiomics for predicting occult cervical lymph nodes metastases in early-stage oral tongue squamous cell carcinoma. Chin J Radiol 12:30–35
Elhalawani H, Fleming CW, Rao S, Chen Y, Hobbs B, Ma T, Kuzmin G, Woody NM, Joshi NP, Chute D, Ku J (2020) Prognostic impact of baseline and delta tumor radiomics features in patients with oropharyngeal cancer (OPC) treated with adaptive image guided radiotherapy (IGRT). Int J Radiat Oncol Biol Phys 108(3):e313
doi: 10.1016/j.ijrobp.2020.07.747
Traverso A, Hosni-Abdalaty A, Hasan M, Kim J, Ringash J, Cho J, Bratman S, Bailey A, Waldron J, Welch M, Irish J (2019) Investigating radiomics to predict positive lymph nodes in oral cavity squamous cell carcinoma (OSCC). Med Phys 46(6):e295
Elhalawani H, Volpe S, Barua S, Mohamed A, Yang P, Ng SP, Lai S, Hutcheson KA, Gunn GB, Rao A, Fuller CD (2018) Exploration of an early imaging biomarker of osteoradionecrosis in oropharyngeal cancer patients: case-control study of the temporal changes of mandibular radiomics features. Int J Radiat Oncol Biol Phys 100(5):1363–1364
doi: 10.1016/j.ijrobp.2017.12.146
Kirienko M, Cozzi L, Rossi A, Voulaz E, Antunovic L, Fogliata A, Chiti A, Sollini M (2018) Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions. Eur J Nucl Med Mol Imaging 45(10):1649–1660. https://doi.org/10.1007/s00259-018-3987-2
doi: 10.1007/s00259-018-3987-2 pubmed: 29623375
Abdel Razek AAK, Mansour M, Kamal E, Mukherji SK (2022) MR imaging of oral cavity and oropharyngeal cancer. Magn Reson Imaging Clin N Am 30(1):35–51. https://doi.org/10.1016/j.mric.2021.07.002
doi: 10.1016/j.mric.2021.07.002 pubmed: 34802580
Lin Y, Tang M, Liu Y, Jiang M, He S, Zeng D, Cui MY (2022) A narrative review on machine learning in diagnosis and prognosis prediction for tongue squamous cell carcinoma. Transl Cancer Res 11(12):4409–4415. https://doi.org/10.21037/tcr-22-1669
doi: 10.21037/tcr-22-1669 pubmed: 36644177 pmcid: 9834582
Kubo K, Kawahara D, Murakami Y, Takeuchi Y, Katsuta T, Imano N, Nishibuchi I, Saito A, Konishi M, Kakimoto N, Yoshioka Y, Toratani S, Ono S, Ueda T, Takeno S, Nagata Y (2022) Development of a radiomics and machine learning model for predicting occult cervical lymph node metastasis in patients with tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 134(1):93–101. https://doi.org/10.1016/j.oooo.2021.12.122
doi: 10.1016/j.oooo.2021.12.122 pubmed: 35431177
Zhong YW, Jiang Y, Dong S, Wu WJ, Wang LX, Zhang J, Huang MW (2022) Tumor radiomics signature for artificial neural network-assisted detection of neck metastasis in patient with tongue cancer. J Neuroradiol 49(2):213–218. https://doi.org/10.1016/j.neurad.2021.07.006
doi: 10.1016/j.neurad.2021.07.006 pubmed: 34358534
Konishi M, Kakimoto N (2023) Radiomics analysis of intraoral ultrasound images for prediction of late cervical lymph node metastasis in patients with tongue cancer. Head Neck 45(10):2619–2626. https://doi.org/10.1002/hed.27487
doi: 10.1002/hed.27487 pubmed: 37584449
Kudoh T, Haga A, Kudoh K, Takahashi A, Sasaki M, Kudo Y, Ikushima H, Miyamoto Y (2023) Radiomics analysis of [18F]-fluoro-2-deoxyglucose positron emission tomography for the prediction of cervical lymph node metastasis in tongue squamous cell carcinoma. Oral Radiol 39(1):41–50. https://doi.org/10.1007/s11282-022-00600-7 . (Erratum In: Oral Radiol. 2022 Jun 11)
doi: 10.1007/s11282-022-00600-7 pubmed: 35254609
Pan X, Zhang T, Yang Q, Yang D, Rwigema JC, Qi XS (2020) Survival prediction for oral tongue cancer patients via probabilistic genetic algorithm optimized neural network models. Br J Radiol 93(1112):20190825. https://doi.org/10.1259/bjr.20190825
doi: 10.1259/bjr.20190825 pubmed: 32520585 pmcid: 7445997
Ren J, Qi M, Yuan Y, Tao X (2021) Radiomics of apparent diffusion coefficient maps to predict histologic grade in squamous cell carcinoma of the oral tongue and floor of mouth: a preliminary study. Acta Radiol 62(4):453–461. https://doi.org/10.1177/0284185120931683
doi: 10.1177/0284185120931683 pubmed: 32536260
Yu B, Huang C, Xu J, Liu S, Guan Y, Li T, Zheng X, Ding J (2021) Prediction of the degree of pathological differentiation in tongue squamous cell carcinoma based on radiomics analysis of magnetic resonance images. BMC Oral Health 21(1):585. https://doi.org/10.1186/s12903-021-01947-9
doi: 10.1186/s12903-021-01947-9 pubmed: 34798867 pmcid: 8603498
Corti A, De Cecco L, Cavalieri S, Lenoci D, Pistore F, Calareso G, Mattavelli D, de Graaf P, Leemans CR, Brakenhoff RH, Ravanelli M, Poli T, Licitra L, Corino V, Mainardi L (2023) MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures. Biomark Res 11(1):69. https://doi.org/10.1186/s40364-023-00494-5
doi: 10.1186/s40364-023-00494-5 pubmed: 37455307 pmcid: 10350277
Jha AK, Sherkhane UB, Mthun S, Jaiswar V, Purandare N, Prabhash K, Wee L, Rangarajan V, Dekker A (2023) External validation of robust radiomic signature to predict 2-year overall survival in non-small-cell lung cancer. J Digit Imaging 36(6):2519–2531. https://doi.org/10.1007/s10278-023-00835-8
doi: 10.1007/s10278-023-00835-8 pubmed: 37735307 pmcid: 10584779
Leemans CR, Snijders PJF, Brakenhoff RH (2018) The molecular landscape of head and neck cancer. Nat Rev Cancer 18(5):269–282. https://doi.org/10.1038/nrc.2018.11 . (Erratum in: Nat Rev Cancer. 2018 Oct;18(10):662)
doi: 10.1038/nrc.2018.11 pubmed: 29497144
Lo Casto A, Cannella R, Taravella R, Cordova A, Matta D, Campisi G, Attanasio M, Rinaldi G, Rodolico V (2022) Diagnostic and prognostic value of magnetic resonance imaging in the detection of tumor depth of invasion and bone invasion in patients with oral cavity cancer. Radiol Med 127(12):1364–1372. https://doi.org/10.1007/s11547-022-01565-7
doi: 10.1007/s11547-022-01565-7 pubmed: 36255660
Park JE, Kim HS, Kim D, Park SY, Kim JY, Cho SJ, Kim JH (2020) A systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging features. BMC Cancer 20(1):29. https://doi.org/10.1186/s12885-019-6504-5
doi: 10.1186/s12885-019-6504-5 pubmed: 31924170 pmcid: 6954557
Jethanandani A, Lin TA, Volpe S, Elhalawani H, Mohamed ASR, Yang P, Fuller CD (2018) Exploring applications of radiomics in magnetic resonance imaging of head and neck cancer: a systematic review. Front Oncol 8:131. https://doi.org/10.3389/fonc.2018.00131
doi: 10.3389/fonc.2018.00131 pubmed: 29868465 pmcid: 5960677
Zhao B, Tan Y, Tsai WY, Qi J, Xie C, Lu L, Schwartz LH (2016) Reproducibility of radiomics for deciphering tumor phenotype with imaging. Sci Rep 6:23428. https://doi.org/10.1038/srep23428
doi: 10.1038/srep23428 pubmed: 27009765 pmcid: 4806325
Salmanpour MR, Hosseinzadeh M, Rezaeijo SM, Rahmim A (2023) Fusion-based tensor radiomics using reproducible features: application to survival prediction in head and neck cancer. Comput Methods Programs Biomed 240:107714. https://doi.org/10.1016/j.cmpb.2023.107714
doi: 10.1016/j.cmpb.2023.107714 pubmed: 37473589
Noortman WA, Aide N, Vriens D, Arkes LS, Slump CH, Boellaard R, Goeman JJ, Deroose CM, Machiels JP, Licitra LF, Lhommel R, Alessi A, Woff E, Goffin K, Le Tourneau C, Gal J, Temam S, Delord JP, van Velden FHP, de Geus-Oei LF (2023) Development and external validation of a pet radiomic model for prognostication of head and neck cancer. Cancers 15(10):2681. https://doi.org/10.3390/cancers15102681
doi: 10.3390/cancers15102681 pubmed: 37345017 pmcid: 10216021

Auteurs

Marta Tagliabue (M)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Department of Biomedical Sciences, University of Sassari, Sassari, Italy.

Francesca Ruju (F)

Division of Radiology, European Institute of Oncology IRCCS, Milan, Italy.

Chiara Mossinelli (C)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy. chiara.mossinelli@ieo.it.

Aurora Gaeta (A)

Department of Statistics and Quantitative Methods, University of Milan-Bicocca, Via Bicocca Degli Arcimboldi, Milan, Italy.
Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.

Sara Raimondi (S)

Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.

Stefania Volpe (S)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Mattia Zaffaroni (M)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.

Lars Johannes Isaksson (LJ)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Cristina Garibaldi (C)

Unit of Radiation Research, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Marta Cremonesi (M)

Unit of Radiation Research, IEO European Institute of Oncology, IRCCS, Milan, Italy.

Anna Rapino (A)

Postgraduate School of Radiodiagnostic, University of Milan, Milan, Italy.

Susanna Chiocca (S)

Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.

Giacomo Pietrobon (G)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

Daniela Alterio (D)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.

Giuseppe Trisolini (G)

Department of Otorhinolaryngology and Skull Base Microsurgery-Neurosciences, ASST Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Patrizia Morbini (P)

Unit of Pathology, E.O. Ospedali Galliera, Genoa, Italy.

Vittorio Rampinelli (V)

Unit of Otorhinolaryngology-Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, 25123, Brescia, Italy.

Alberto Grammatica (A)

Unit of Otorhinolaryngology-Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, 25123, Brescia, Italy.

Giuseppe Petralia (G)

Division of Radiology, European Institute of Oncology IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Barbara Alicja Jereczek-Fossa (BA)

Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

Lorenzo Preda (L)

Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy.
Radiology Institute, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Marco Ravanelli (M)

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, School of Medicine, Brescia, Italy.

Roberto Maroldi (R)

Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, School of Medicine, Brescia, Italy.

Cesare Piazza (C)

Unit of Otorhinolaryngology-Head and Neck Surgery, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, ASST Spedali Civili of Brescia, University of Brescia, 25123, Brescia, Italy.

Marco Benazzo (M)

Diagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy.
Department of Otorhinolaryngology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Mohssen Ansarin (M)

Division of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141, Milan, Italy.

Classifications MeSH